Australia Hits Pfizer With Antitrust Suit Over Lipitor

Law360, New York (February 13, 2014, 1:06 PM EST) -- Australia's competition regulator has sued the domestic unit of Pfizer Inc. over its marketing of the cholesterol-lowering drug Lipitor to pharmacies as the patent protection for the drug was about to expire, alleging the manufacturer abused its market power, the country's antitrust watchdog announced Thursday.

The Australian Competition and Consumer Commission alleged that financial incentives Pfizer Australia Pty Ltd. offered to retailers to stock up on a large supply of Lipitor and Pfizer's own generic form of the drug, atorvastatin, before it faced competition from generic-drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.